期刊
CHEMMEDCHEM
卷 17, 期 17, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.202200207
关键词
antimicrobial; drug discovery; Gram-positive bacteria; MRSA; structure-activity relationships; thieno[2; 3-d]pyrimidine
资金
- Federal Ministry of Education and Research (BMBF) of Germany [FKZ 03ZZ0835 A, 03ZZ0826 A]
- Russian Science Foundation [21-15-00042]
Thieno[2,3-d]pyrimidines represent a novel antibacterial prodrug scaffold with potential antibacterial effects against Gram-positive bacteria, particularly Staphylococci (MRSA). The two most promising hit compounds demonstrate good pharmacokinetic properties in vitro and acceptable toxicity, qualifying them as starting points for lead-generation campaigns.
Thieno[2,3-d]pyrimidines represent a novel antibacterial prodrug scaffold, previously identified through a screening campaign against Mycobacterium tuberculosis in which the formation of highly antimycobacterial metabolites catalyzed by the nitroreductase Mrx2 is suggested to be the relevant killing mechanism. As analogous activation pathways may also be employed in other prokaryotes, in this work we explored general antibacterial effects of this compound class. Through exploration of the chemical space by different synthetic strategies, 51 novel derivatives were generated, biologically evaluated and thus enabled initial conclusions about structure-activity relationships. Remarkably, anti-Gram-positive activity can be well modulated, particularly towards Staphylococci (MRSA) and even slightly against some Gram-negative strains. The two most promising hit compounds showed good pharmacokinetic properties in vitro as well as acceptable toxicity in HeLa cells, qualifying them as starting points for lead-generation campaigns.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据